Stocks and Investing Stocks and Investing
Wed, March 31, 2021
Tue, March 30, 2021
Mon, March 29, 2021
Fri, March 26, 2021
Thu, March 25, 2021
Wed, March 24, 2021

Jason Gerberry Downgraded (BHC) to Sell and Held Target at $27 on, Mar 24th, 2021


Published on 2024-10-27 16:01:40 - WOPRAI, Jason Gerberry
  Print publication without navigation


Jason Gerberry of B of A Securities, Downgraded "Bausch Health Companies Inc." (BHC) to Sell and Held Target at $27 on, Mar 24th, 2021.

Jason has made no other calls on BHC in the last 4 months.



There are 4 other peers that have a rating on BHC. Out of the 4 peers that are also analyzing BHC, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Maintained at Hold with Increased Target to $35 on, Friday, February 26th, 2021


These are the ratings of the 3 analyists that currently disagree with Jason


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $55 on, Tuesday, March 16th, 2021
  • Douglas Miehm of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $42 on, Wednesday, February 17th, 2021
  • David Steinberg of "Jefferies" Maintained at Strong Buy with Increased Target to $33 on, Friday, January 15th, 2021